当前位置:Public Access >页面
Chinese/English
Construction of Clinical Evaluation Technology Platform for New Drugs of Major Diseases--Exploring New Eradication Treatment Program for Drug-Resistant Helicobacter Pylori

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR1900023228

研究题目:

Construction of Clinical Evaluation Technology Platform for New Drugs of Major Diseases--Exploring New Eradication Treatment Program for Drug-Resistant Helicobacter Pylori

Study title:

Construction of Clinical Evaluation Technology Platform for New Drugs of Major Diseases--Exploring New Eradication Treatment Program for Drug-Resistant Helicobacter Pylori

 注册状况:

 Registration:

False

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

13811519095

电子邮件

Email

luoqf2000@126.com

通讯地址:

北京市东城区东单大华路1号

Address:

1 Dongdan Dahua Road, Dongcheng District, Beijing, China

邮政编码

Postcode

100010

项目负责人所有单位:

北京医院

Institution:

Beijing Hospital

批准本研究的伦理委员会名称:

北京医院伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing Hospital

研究疾病:

Study Ailment:

研究所处阶段:

Study phase:

研究类型:

Type of Study:

研究团队:

罗庆锋、许乐、刘方旭、郑小丽、史济华、徐雪、王奕然、鲁芳淇、靳蕊

Research team:

Luo Qingfeng, Xu Le, Liu Fangxu, Zheng Xiaoli, Shi Jihua, Xu Xue, Wang Yiran, Lu Fangqi, Jin Rui

研究实施地点:

Site of Study:

国家(地区):

省(直辖市):

市(区县):

Country/Area:

Province:

City:

单位
Institution

预计起止时间:

Planned Duration:

2019-02-01 00:00:00-2020-12-31 00:00:00